Our Team
Ron Roscia - CEO
The Founder and CEO of RxDNA Inc, a true entrepreneur who built a next-generation PBM consulting and technology firm from the ground up. With a bold vision to disrupt the status quo, Ron has redefined how pharmacy benefits are sourced, priced, and managed. Under his leadership, RxDNA has developed a high-tech platform that merges proposal automation, transparent analytics, and clinical intelligence empowering brokers, consultants, and employers to make smarter, faster, and more transparent benefit decisions.
With over 20 years of executive experience across healthcare and employee benefits including roles at Wells Fargo, Optum, USI, and Capital Rx. Ron is the strategic force behind RxDNA’s operations and client relationships. He works directly with health plans, large employers, municipalities, unions, and Taft-Hartley Funds to drive measurable savings, reduce complexity, and implement innovative alternative funding models that produce real results.
A recognized thought leader in the PBM space, Ron is known for cutting through industry noise with sharp insights and transparent contracting strategies. He serves on multiple national advisory councils, including groups influencing Congressional reform focused on benefit integrity and healthcare cost containment.
Outside the RxDNA boardroom, Ron is a committed community leader. He serves on the boards of SHRM and Duquesne University’s Alumni Chapter, and is a board member of Catholic Charities. He’s also an active member of the Ocean Reef Club and the New York Athletic Club and serves as head coach for the Cyclones U18 youth hockey team.
Denise Rebeor - VP of Business Development
With over 25 years of executive leadership across the pharmaceutical, biotech, diagnostics, and PBM industries, Denise brings unparalleled expertise and vision to RxDNA’s mission of smarter, more transparent pharmacy benefit management. She has held senior roles with leading organizations like Merck and ProAct, and has been instrumental in driving innovation across pharmacogenomics, cancer diagnostics, molecular testing, and regenerative medicine.
Denise’s career is built on results and relentless innovation launching nationally recognized therapies and diagnostics, while pioneering regenerative wellness programs such as MSC stem cell treatments for patients with chronic and autoimmune conditions. At RxDNA, she leads strategic broker and consultant engagement, empowering self-funded employer groups to expose hidden costs, manage specialty drug challenges, and adopt benefit strategies grounded in clinical and financial integrity.
Her leadership style blends clinical acumen with strong industry relationships and future-focused thinking. Denise is known for her friendly but persistent engagement to deliver a client-first approach and her commitment to delivering actionable, real-time insights through RxDNA’s rapid RFP platform.
Outside of work, Denise enjoys her family and dear friends while traveling, playing tennis, cooking, gardening, volunteering, and discovering new local gems.
Michael Paez - Business Development | Account Manager
Serves as a driving force at RxDNA, where he leads Business Development and Account Management efforts to deliver intelligent, high-impact pharmacy benefit solutions. With a unique background in healthcare analytics, logistics, and media relations, Michael brings a dynamic, results-oriented mindset to every client engagement.
At RxDNA, Michael works closely with brokers, consultants, and employer groups to streamline PBM procurement through the firm’s proprietary RFP platform—automating complex processes, delivering real-time insights, and uncovering meaningful cost savings. His ability to translate data into actionable strategy makes him a trusted advisor for clients navigating pharmacy benefit design, contract transparency, and performance optimization.
Michael’s professional journey includes data roles at the University of Miami and the Miami HEAT, where he developed deep analytical acumen and a strong focus on operational excellence. That same precision and passion now fuels his work at RxDNA, helping clients make smarter, faster decisions in an increasingly complex healthcare landscape.